The Future of Medicine: Sperm Cells Transformed into Programmable Micro-Robots
A New Horizon for Lymphoma Patients: InnoCare's HIBRUCA Approved in Singapore for Marginal Zone Lymphoma
Exelixis Shakes Up Operations: Pennsylvania Site Closes, 130 Jobs Affected in Strategic Realignment
Unlocking Monopar's Potential: A Speculative Bet on Imminent Cancer Breakthroughs
The Future is Here: Scientists Engineer 'Sperm-Bots' for Revolutionary Targeted Drug Delivery
Carisma Therapeutics Shares Soar Over 130% on Groundbreaking Moderna Collaboration for In Vivo CAR-M Therapies
TYRA Biosciences Ignites Hope with Strong Q2 2025 Results and Promising Pipeline Progress